Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
about
Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infectionsBacteriophage T4 GenomeMorphological, host range, and genetic characterization of two coliphagesThe murky origin of Snow White and her T-even dwarfsBacteriophage therapyNatural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Dynamics of success and failure in phage and antibiotic therapy in experimental infectionsFunctional Studies of ssDNA Binding Ability of MarR Family Protein TcaR from Staphylococcus epidermidisMycobacteriophage and their application to disease controlIsolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolatesThe threat of antimicrobial resistance in developing countries: causes and control strategies.Display technologies: application for the discovery of drug and gene delivery agents.Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.MM1, a temperate bacteriophage of the type 23F Spanish/USA multiresistant epidemic clone of Streptococcus pneumoniae: structural analysis of the site-specific integration system.Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease controlBiocontrol of Escherichia coli O157 with O157-specific bacteriophages.Bacteriophage-based synthetic biology for the study of infectious diseases.Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain.Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env.Complete genome sequence analysis of two Pseudomonas plecoglossicida phages, potential therapeutic agents.Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattleExposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients.Vancomycin resistance: occurrence, mechanisms and strategies to combat it.Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages.Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in miceIn vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.Bacteriophages as biocontrol agents in food.Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activityLearning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the WestBacteriophage biocontrol in animals and meat products.Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens.What are the limitations on the wider therapeutic use of phage?Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool.Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms.Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains.
P2860
Q21136065-59B28883-97F4-4915-8640-53675052E708Q22061798-4CFCBB8C-4EB0-4A5D-A993-2B81980EEAF8Q23916775-FE395649-BBAA-42DC-9F8C-F4F01140425AQ24548117-8998631A-9AA7-4906-AD28-E0346B7E8E1EQ24550616-AA5F8C2A-8E3F-406A-88C1-9670F3400A02Q24563742-57097627-AFC2-4327-82CB-773150CE51F2Q24803578-A2188382-8C27-4E6B-A929-4D5742A143F3Q27673989-FE5166A7-DE85-440A-8447-319ECD7ECCA3Q28262790-E5283B81-FCE1-4D55-97A6-211A1FAAA576Q28727951-F2AE9F69-8FFF-43C7-848F-D90A6718EA55Q30234424-8F4955F2-0FAD-4D27-B097-59B5D6E84FE3Q33264491-2D41B1D3-2733-40FC-A4ED-CFDE4415DA80Q33567388-758A9753-F5DB-4BE3-A23B-C8063FC38EB5Q33810389-7A1E1158-7541-4143-80C2-CB7AC734A9B2Q33986903-BD95A99B-5480-45AA-BDBE-9542089D4DC4Q34012025-59F59006-FB25-4D06-8C3E-6A3D4005D812Q34017160-A72FEAED-719F-42E7-8FC6-51E68DD72FCDQ34116507-278B3DCA-0210-4068-ACDC-18E8108AE6C3Q34290420-868B7C8F-130D-436C-B23C-7CA39D61632AQ34426663-18502186-6DB7-40C0-8DD9-EAF7CE935D98Q34706815-4ACC050F-FA97-4CD8-A6B0-244336CD7680Q34933970-4EF7D71B-46EA-4124-A5DC-3D66DDA19583Q35023248-B487096B-C5AA-40E9-A220-C80641C16A65Q35130454-CB403DEC-A858-4C16-B4E1-1FB6DBCDD67DQ35143886-E7195340-F081-450F-A0D0-EAB455933245Q35210425-8FE8AB2C-3A98-4716-9770-F0C6C6A68491Q35635891-8701A203-923A-4857-B43B-C9EDFD3D1EDAQ35780029-E4C6F620-90A0-4F2E-9F38-4B5EEC785CE7Q36052554-32815FDC-3A17-4457-A5B5-75555F8521E8Q36499644-251A166A-D09C-476D-B5A2-4D783B4454E2Q36676044-EC2DBD47-C2DF-4BF4-8161-9BAB1E0BFCFAQ36891010-0FD648CE-AC68-4D74-A88C-7A4A2AAE8A36Q37273445-7411D0CC-1723-4A98-A722-ACE2CE385E3FQ37283951-99105E57-5C60-4B86-8F04-56C48E01A06DQ37291441-B409F9A0-2E55-4CF5-8780-4BDD1B813CBCQ37855846-316842BA-AECF-4C01-9117-A74ABC23E6A5Q38225652-F0E4F098-8707-43F6-83DB-BB6E8B80AE01Q39374494-095B363C-B4FC-4CDC-94D9-73D4173ADA0BQ39491332-A15606F2-9B7E-4D19-A579-547B5C1F1F71Q39493523-DF06F6FC-80A0-4613-A0F9-9A3A36E114FD
P2860
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
@en
type
label
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
@en
prefLabel
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
@en
P1476
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
@en
P2093
Soothill JS
P304
P356
10.1016/S0966-842X(97)01054-8
P577
1997-07-01T00:00:00Z